CGON
CG Oncology, Inc.
NASDAQ · Healthcare · Biotechnology · US
$67.71
+5.70%Forward multiples
Based on analyst estimates
- P/E forward
- —
- P/E 2026E
- —
- P/E 2027E
- —
- P/E 2028E
- —
- P/S forward
- 111.46x
Trailing multiples
Trailing twelve months
- P/E TTM
- —
- PEG TTM
- —
- Price / book
- 5.83x
- Price / sales
- 963.69x
- Price / cash flow
- -33.63x
Enterprise value
- Enterprise value
- $5.0B
- EV / sales
- 800.00x
- EV / EBITDA
- -22.50x
- EV / EBIT
- -19.72x
- Market cap
- $6.0B
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Jun 1, 2026